Cargando…

Sensitive Determination of SARS-COV-2 and the Anti-hepatitis C Virus Agent Velpatasvir Enabled by Novel Metal–Organic Frameworks

[Image: see text] Herein, we report on the electrochemical determination of velpatasvir (VLP) as the main constituent of Epclusa, a SARS-COV-2 and anti-hepatitis C virus (HCV) agent, using a novel metal–organic framework (MOF). The NH(2)-MIL-53(Al) MOF was successfully modified with 5-bromo-salicyla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saleh, Mahmoud A., Mohamed, Mona A., Shahat, Ahmed, Allam, Nageh K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515823/ https://www.ncbi.nlm.nih.gov/pubmed/34661033 http://dx.doi.org/10.1021/acsomega.1c04525

Ejemplares similares

Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C
Publicado: (2019)

Profile of sofosbuvir/velpatasvir/voxilaprevir in the treatment of hepatitis C
por: Childs-Kean, Lindsey M, et al.
Publicado: (2019)

Sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir: novel treatment options for naïve and previously treated hepatitis C infection
por: Shin, Hyun Phil
Publicado: (2023)

Efficacy and safety of sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir for hepatitis C in Korea: a Phase 3b study
por: Heo, Jeong, et al.
Publicado: (2023)

Sofosbuvir/Velpatasvir for the treatment of Hepatitis C Virus infection
por: Anna, Linda Zignego, et al.
Publicado: (2018)

Graphitic Carbon Nitride Nanoheterostructures as Novel Platforms for the Electrochemical Sensing of the Chemotherapeutic and Immunomodulator Agent MTX
por: Elfarargy, Reham G., et al.
Publicado: (2022)

Sofosbuvir/Velpatasvir - A Promising Treatment for Chronic Hepatitis C Virus Infection
por: Ahmed, Rowan, et al.
Publicado: (2021)

Sofosbuvir-Velpatasvir (Epclusa)-Associated Photosensitivity in a Hepatitis C Patient: Case Report and Review of Photosensitivity to Hepatitis C Antiviral Agents
por: Glombicki, Stephen E, et al.
Publicado: (2021)

Sofosbuvir/velpatasvir regimen promises an effective pan-genotypic hepatitis C virus cure
por: Mir, Fazia, et al.
Publicado: (2017)

Selective and sensitive spectrofluorimetric quantification of velpatasvir in presence of sofosbuvir. Application to their co-formulated tablet
por: El-Gamal, Rania M., et al.
Publicado: (2018)

Metal–Organic Frameworks as Potential Agents for Extraction and Delivery of Pesticides and Agrochemicals
por: Mahmoud, Lila A. M., et al.
Publicado: (2022)

Estimating the net value of treating hepatitis C virus using sofosbuvir-velpatasvir in India
por: Bloom, David E., et al.
Publicado: (2021)

Achieving the Sustained Virologic Response With a Short-Course Treatment of Sofosbuvir/Velpatasvir
por: Abi-Saleh, Simon P, et al.
Publicado: (2023)

Postsynthetic Modification: An Enabling Technology for the Advancement of Metal–Organic Frameworks
por: Kalaj, Mark, et al.
Publicado: (2020)

A Highly Sensitive and Flexible Metal–Organic Framework Polymer-Based H(2)S Gas Sensor
por: Ali, Ashraf, et al.
Publicado: (2021)

Sofosbuvir, Velpatasvir, and Voxilaprevir for Treatment of Recurrent Hepatitis C Virus Infection After Liver Transplantation
por: Cardona‐Gonzalez, Maria G., et al.
Publicado: (2018)

Efficacy and Safety of Sofosbuvir and Velpatasvir Combination for the Treatment of Chronic Hepatitis C in Patients With or Without Cirrhosis
por: Shah, Islam, et al.
Publicado: (2021)

Safety and efficacy of sofosbuvir-velpatasvir: A meta-analysis
por: Ren, Xiao-Dan, et al.
Publicado: (2022)

Porphyrin NanoMetal-Organic Frameworks as Cancer Theranostic Agents
por: Figueira, Flávio, et al.
Publicado: (2022)

Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir‐containing regimen: Results from a retreatment study
por: Ruane, Peter, et al.
Publicado: (2019)

Refractory plasmonics enabling 20% efficient lead-free perovskite solar cells
por: Mohsen, Ahmed A., et al.
Publicado: (2020)

Microbial reduction of metal-organic frameworks enables synergistic chromium removal
por: Springthorpe, Sarah K., et al.
Publicado: (2019)

Metal-organic frameworks enable broad strategies for lithium-sulfur batteries
por: Zhou, Cheng, et al.
Publicado: (2021)

Chemo-Biocascade Reactions Enabled by Metal–Organic Framework Micro-Nanoreactor
por: Zhang, Jing, et al.
Publicado: (2022)

Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis
por: Flamm, Steven, et al.
Publicado: (2023)

Metal and Covalent Organic Frameworks for Membrane Applications
por: Fang, Mingyuan, et al.
Publicado: (2020)

Location determination of metal nanoparticles relative to a metal-organic framework
por: Chen, Yu-Zhen, et al.
Publicado: (2019)

Metal-organic framework enables ultraselective polyamide membrane for desalination and water reuse
por: Wen, Yue, et al.
Publicado: (2022)

Effectiveness and Safety of Sofosbuvir-Velpatasvir in Patients with Cirrhosis Associated with Genotype 3 Hepatitis C Infection in Xinjiang, China
por: Abulitifu, Yilihamu, et al.
Publicado: (2022)

Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis
por: Kotani, Kohei, et al.
Publicado: (2023)

Sofosbuvir and Velpatasvir Regimen Outcome for Chronic Hepatitis C Patients With End-Stage Renal Disease Undergoing Hemodialysis
por: Shahid, Salman, et al.
Publicado: (2023)

Enhanced dispersive solid phase extraction assisted by cloud point strategy prior to fluorometric determination of anti-hepatitis C drug velpatasvir in pharmaceutical tablets and body fluids
por: El-Wekil, Mohamed M., et al.
Publicado: (2018)

Structure sensitivity in gas sorption and conversion on metal-organic frameworks
por: Delen, Guusje, et al.
Publicado: (2023)

Sofosbuvir/velpatasvir in treatment-experienced HCV-infected patients – short report
por: Piekarska, Anna, et al.
Publicado: (2020)

Electrochemical Determination of the Serotonin Reuptake Inhibitor, Dapoxetine, Using Cesium–Gold Nanoparticles
por: Mohamed, Mona A., et al.
Publicado: (2017)

Real-world effectiveness and safety of sofosbuvir/velpatasvir and ledipasvir/sofosbuvir hepatitis C treatment in a single centre in Germany
por: Buggisch, Peter, et al.
Publicado: (2019)

Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan
por: Huang, Yu-Ting, et al.
Publicado: (2021)

Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
por: Liu, Chen-Hua, et al.
Publicado: (2021)

Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
por: Cheng, Pin-Nan, et al.
Publicado: (2021)

Efficacy and safety of sofosbuvir/velpatasvir with or without ribavirin in hepatitis C genotype 3 compensated cirrhosis: A meta-analysis
por: Loo, Jing Hong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_crrvk56dr2bv803r6qs3h9vom1